Phase I Study of HSK41959 in Solid Tumors With MTAP Deletion

NCT06968572 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

245

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: HSK41959

Sponsor

Haisco Pharmaceutical Group Co., Ltd.